Julie Papanek, Director at Protagonist Therapeutics, Inc (PTGX), bought 2,453,255 shares at $12.00 ($7.0M) on 2016-08-16, disclosed to the SEC on 2016-08-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,869,922 | $0 | 0.0% |
| 2 | $12.00 | 583,333 | $7.0M | 100.0% |
| Total | $2.85 avg | 2,453,255 | $7.0M | 100% |